Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding
NCT ID: NCT01031342
Last Updated: 2011-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
72 participants
INTERVENTIONAL
2002-08-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who are admitted with bleeding from their rectum and a negative endoscopic exam of the stomach and upper intestine are randomized (like flipping a coin) to receive a colonsoscopy either as an emergency (within 12 hours) or as a routine procedure (36 hours after admission). Patients are followed during their hospitalization to see if they have further bleeding, if they require blood transfusions, if they need other diagnostic tests, if they need surgery or other treatments, and how long they stay in the hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Early Versus Elective Colonoscopy
NCT03098173
Effect of Inadequate Bowel Preparation on Urgent Colonoscopy in Patients With PPB.
NCT04468737
Oral PEG vs. Enema in Urgent Colonoscopy for ALGIB
NCT06254443
Postpolypectomy Bleeding in Patients With Antiplatelet Therapy
NCT01465256
High-Volume Vs Low-Volume Preparation in Emergency Department
NCT05362227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who are admitted with bleeding from their rectum and clinical evidence of a significant bleeding episode (elevated heart rate, low blood pressure, or need for blood transfusion) have immediate upper endoscopy (examination of the stomach with a flexible rubber tube with a light and video camera on the end). If this shows no source of bleeding, the patients are randomized (like flipping a coin) to receive a colonsoscopy (examination of the large intestine with a flexible rubber tube with a light and video camera on the end) either as a emergency (within 12 hours) or as a routine procedure (36 hours after admission).
Patients are followed during their hospitalization to see if they have further bleeding, if they require blood transfusions, if they need other diagnostic tests, if they need surgery or other treatments, and how long they stay in the hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early colonoscopy
Colonoscopy performed within 12 hours of presentation
Early colonoscopy
Colonoscopy within 12 hours of presentation
Elective colonoscopy
Colonoscopy 36-60 hours after presentation
Elective colonoscopy
Colonoscopy 36-60 hours after presentation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early colonoscopy
Colonoscopy within 12 hours of presentation
Elective colonoscopy
Colonoscopy 36-60 hours after presentation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. HR \> 100/min
2. Systolic blood pressure \<100 mmHg
3. Orthostasis -considered as increase in HR by\> 20/min on assuming erect position as well as by decrease by 20 mmHg in systolic blood pressure
4. Need for blood transfusion
5. Drop in hemoglobin \> 1.5 g/dl or in hematocrit of \> 6% in 6 hours
Exclusion Criteria
2. Peritoneal signs
3. Severe co-morbidities that would preclude the use of colonoscopy in standard clinical practice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Southern California
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Loren Laine, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Southern California
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
L.A. County + U.S.C. Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-025014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.